Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Bizlère, K.
and
Berger, M.
1990.
Efficacy of a reversible monoamine oxidase‐A inhibitor versus imipramine in subgroups of depressed patients.
Acta Psychiatrica Scandinavica,
Vol. 82,
Issue. S360,
p.
59.
Newburn, Gil M.
Fraser, Allen R.
Menkes, David B.
and
Mullen, Paul E.
1990.
A Double Blind Trial of Moclobemide versus Amltrlptyllne in the Treatment of Depressive Disorders.
Australian & New Zealand Journal of Psychiatry,
Vol. 24,
Issue. 4,
p.
475.
Versiani, M.
Nardi, A. E.
Figueira, I. L. V.
and
Stabl, M.
1990.
Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase‐A, compared with other antidepressants and placebo.
Acta Psychiatrica Scandinavica,
Vol. 82,
Issue. S360,
p.
24.
Larsen, J. K.
Gjerris, A.
Holm, P.
Andersen, J.
Bille, A.
Christensen, E. M.
Høyer, E.
Jensen, H.
Mejlhede, A.
Langagergaard, A.
Laursen, A. L.
Nilakantan, B.
Olafsson, K.
Severin, B.
and
Rafaelsen, O. J.
1991.
Moclobemide in depression: a randomized, multicentre trial against isocarboxazide and clomipramine emphasizing atypical depression.
Acta Psychiatrica Scandinavica,
Vol. 84,
Issue. 6,
p.
564.
Elphick, Martin
1991.
Vol. 15,
Issue. ,
p.
11.
Bandelow, B.
and
Rüther, E.
1991.
Neurotransmitter und psychische Erkrankungen.
p.
29.
Versiani, M.
Nardi, A. E.
Mundim, F. D.
Alves, A. B.
Liebowitz, M. R.
and
Amrein, R.
1992.
Pharmacotherapy of Social Phobia.
British Journal of Psychiatry,
Vol. 161,
Issue. 3,
p.
353.
Guelfi, J. D.
Payan, C.
Fermanian, J.
Pedarriosse, A. M.
and
Manfredi, R.
1992.
Moclobemide Versus Clomipramine in Endogenous Depression.
British Journal of Psychiatry,
Vol. 160,
Issue. 4,
p.
519.
Angst, J.
and
Stabl, M.
1992.
Efficacy of moclobemide in different patient groups: a meta-analysis of studies.
Psychopharmacology,
Vol. 106,
Issue. S1,
p.
S109.
Cesura, Andrea M.
and
Pletscher, Alfred
1992.
Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques.
p.
171.
Tiller, John W.G.
1993.
Clinical overview on moclobemide.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 17,
Issue. 5,
p.
703.
Fahy, T J
1993.
Side effects of moclobemide in depressed patients refractory to other treatments.
Irish Journal of Psychological Medicine,
Vol. 10,
Issue. 1,
p.
24.
Möller, H.-J.
1993.
Biologische Psychiatrie der Gegenwart.
p.
318.
Angst, Jules
1993.
Severity of depression and benzodiazepine comedication in relationship to efficacy of antidepressants in acute trials. A meta‐analysis of moclobemide trials.
Human Psychopharmacology: Clinical and Experimental,
Vol. 8,
Issue. 6,
p.
401.
Da̧bkowska, M.
and
Rybakowski, J.K.
1993.
Moclobemide in treatment-resistant depression.
European Neuropsychopharmacology,
Vol. 3,
Issue. 3,
p.
328.
Angst, J.
Gachoud, J.‐P.
Gasser, U. E.
and
Köhler, M.
1993.
Antidepressant therapy with moclobemide in primary care practice.
Human Psychopharmacology: Clinical and Experimental,
Vol. 8,
Issue. 5,
p.
319.
1993.
Moclobemide: a reversible MAO-A-inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter study.
Journal of Affective Disorders,
Vol. 28,
Issue. 2,
p.
105.
Frazer, Alan
1994.
Antidepressant drugs.
Depression,
Vol. 2,
Issue. 1,
p.
1.
1994.
▼Moclobemide for depression.
Drug and Therapeutics Bulletin,
Vol. 32,
Issue. 1,
p.
6.
Lonnqvist, J.
Sintonen, H.
Syvälahti, E.
Appelberg, B.
Koskinen, T.
Mannikko, T.
Mehtonen, O.‐P.
Naarala, M.
Sihvo, S.
Auvinen, J.
and
Pitkanen, H.
1994.
Antidepressant efficacy and quality of life in depression: a double‐blind study with moclobemide and fluoxetine.
Acta Psychiatrica Scandinavica,
Vol. 89,
Issue. 6,
p.
363.
eLetters
No eLetters have been published for this article.